Companies achieve net zero emissions by cutting greenhouse gas emissions to as close to zero as possible, with any remaining emissions then “offset.” The 18 major pharmaceutical companies analyzed in this report have committed to a target for reducing emissions or achieving net zero emissions. Most pharmaceutical companies have started reducing Scope 1 and 2 emissions by using more renewable energy reducing the carbon footprints of their products. Pharmaceutical companies are also setting targets for suppliers to adopt emissions targets.
All major pharmaceutical companies have committed to reducing their greenhouse gas emissions. To achieve these goals they are adapting their operations and products and are increasingly engaging with suppliers to reduce emissions across their supply chain.
All major pharmaceutical companies have committed to reducing their greenhouse gas emissions. To achieve these goals they are adapting their operations and products and are increasingly engaging with suppliers to reduce emissions across their supply chain.
Scope
- This report provides an overview of the greenhouse gas emissions reduction targets, data, and strategies of 18 leading pharmaceutical companies.
- Understand how pharmaceutical companies are investing to achieve net zero and how this will impact their supply chains. Understand the key climate risks that pharmaceutical companies face. Benchmark emissions data and targets and see which companies are leading in reducing emissions.
Reasons to Buy
- Understand the environmental footprint of pharmaceutical operations
- Enhance the company's reputation by demonstrating a commitments to environmental responsibility
- Gain insights into current environmental regulations
Table of Contents
- Executive Summary
- Why Pharmaceutical Companies Need a Net Zero Strategy
- Emissions Targets and Performance
- Scope 1 and 2 Emissions Strategies
- Scope 3 Emissions Strategies
- Glossary
- Further Reading
- Thematic Research Methodology
- Contact the Publisher
